Overview

Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment in Pregnant Women

Status:
Completed

Trial end date:
2008-03-01

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to compare the drug levels of sulfadoxine-pyrimethamine found when given to pregnant women for the prevention of malaria to those found in pregnant women given the same drug with artesunate for the treatment of malaria, and also with those drug levels found in non-pregnant women in other malaria treatment studies.

Phase:

N/A

Details

Lead Sponsor:

Professor Karen I Barnes

Collaborators:

Global Fund
Medical Research Council, South Africa

Treatments:

Fanasil, pyrimethamine drug combination
Pyrimethamine
Sulfadoxine